Regeneron says its antibody cocktail likely weakened by Omicron variant
(HealthDay)—Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant.
Nov 30, 2021
0
1